![](https://investorshub.advfn.com/uicon/652231.png?cb=1520834748)
Thursday, October 17, 2019 8:37:42 AM
8K for material event : PR on application for approval o second product
https://last10k.com/sec-filings/fomx/0001178913-19-002482.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=fomx
PR
http://www.globenewswire.com/news-release/2019/10/17/1931120/0/en/Foamix-Announces-FDA-Acceptance-of-its-New-Drug-Application-for-FMX103-Minocycline-Foam-for-the-Treatment-of-Moderate-to-Severe-Papulopustular-Rosacea.html
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM